WeightWatchers reported a decrease in total revenues and subscribers for the fourth quarter of fiscal year 2024 compared to the prior year. However, the company achieved significant growth in its Clinical business, with Clinical Subscription Revenues increasing by 57.9% and Clinical Paid Weeks by 53.3%. Profitability metrics such as Gross Margin, Operating Income, and Net Income showed substantial year-over-year improvements, driven by cost management initiatives.
Total revenues for Q4 2024 were $184.4 million, a 10.5% decrease from the prior year period.
The company reported a net income of $25.1 million for Q4 2024, a significant improvement from a net loss of $88.1 million in the prior year period.
End of Period Subscribers decreased by 12.2% to 3.3 million, primarily due to declines in Digital and Workshops + Digital businesses.
Clinical Subscription Revenues grew by 57.9% to $20.5 million, reflecting strong momentum in the Clinical business.
The company is not providing full year fiscal 2025 guidance at this time.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance